Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19: Multi-central Prospective Study
Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19: Multi-central Prospective Study
Low radiation doses produce anti-inflammatory effects, which may be useful in the treatment of respiratory complications of COVID-19. This type of treatment is non-invasive and therefore, a priori, it can be used in all types of patients.
Main objective: To evaluate the efficacy of low-dose lung irradiation as an adjunctive treatment in interstitial pneumonia in patients with COVID-19 by improving the PAFI O2 by 20% measured 48h after treatment with respect to the pre baseline measurement. -irradiation.
Study design: This is a prospective multicenter study in 2 phases:
Inclusion Criteria:
Age >=18 years old
Moderate to severe COVID-19 pneumonia with fewer than 8 days of symptom onset and currently receiving standard medication for COVID-19 at appropriate doses
PAFIO2 of less than 300 mmHg or SaFI02 <315 mmHg
Patients who are not candidates for admission to the Intensive Care Unit due to age, concomitant diseases or general condition.
One of the following conditions:
or IL6 greater than 40
or PCR> 100mg / l
Have read the information sheet and signed the informed consent
Exclusion Criteria:
angel.monteroluis@gmail.com+34667767601
MAlgara@parcdesalutmar.cat
amontero@hmhospitales.com+34915629949